ETFs That Hold Biocryst Pharmaceuticals (BCRX)
Like Biocryst Pharmaceuticals but not the single-stock risk? Find every fund that holds it, ranked by how much. Flip the lens to find the cleanest way to own it, the most diversified wrapper, or (in avoidance mode) which of your funds sneak it in.
Reverse lookup across 335 global listings · ranked by portfolio weight. Weights are the latest holdings each fund reported, refreshed in the background, so the weights and the holder, issuer and listing counts this page prints can all shift between two loads. Fee and assets are joined for every holder from the nightly fund profile, not read live. Exposure data is decision-support, not a recommendation · Not investment advice.
Common questions
How many ETFs hold Biocryst Pharmaceuticals (BCRX)?
Biocryst Pharmaceuticals (BCRX) is held by 75 US-listed ETFs, in each fund's latest reported holdings.
Which ETF holds the most Biocryst Pharmaceuticals?
Of the US-listed ETFs in our fund data, Invesco Biotechnology & Genome ETF (PBE) holds Biocryst Pharmaceuticals at the largest portfolio weight, in each fund's latest reported holdings.
What ETFs hold Biocryst Pharmaceuticals?
By portfolio weight, the US-listed ETFs that hold the most Biocryst Pharmaceuticals are PBE, SBIO, BBP, FDLS and ABLS, among others, in each fund's latest reported holdings.

